Zepp Health Quick Ratio 2017-2025 | ZEPP
Historical quick ratio values for Zepp Health (ZEPP) over the last 10 years.
| Zepp Health Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2025-06-30 | $0.19B | $0.25B | 0.78 |
| 2025-03-31 | $0.18B | $0.21B | 0.84 |
| 2024-12-31 | $0.20B | $0.20B | 1.00 |
| 2024-09-30 | $0.20B | $0.23B | 0.87 |
| 2024-06-30 | $0.20B | $0.20B | 1.02 |
| 2024-03-31 | $0.20B | $0.16B | 1.26 |
| 2023-12-31 | $0.23B | $0.16B | 1.50 |
| 2023-09-30 | $0.24B | $0.17B | 1.41 |
| 2023-06-30 | $0.26B | $0.19B | 1.38 |
| 2023-03-31 | $0.26B | $0.18B | 1.49 |
| 2022-12-31 | $0.28B | $0.24B | 1.16 |
| 2022-09-30 | $0.29B | $0.30B | 0.99 |
| 2022-06-30 | $0.34B | $0.34B | 0.99 |
| 2022-03-31 | $0.34B | $0.34B | 0.98 |
| 2021-09-30 | $0.41B | $0.33B | 1.24 |
| 2021-06-30 | $0.45B | $0.38B | 1.20 |
| 2021-03-31 | $0.31B | $0.36B | 0.86 |
| 2020-12-31 | $0.55B | $0.43B | 1.29 |
| 2020-09-30 | $0.64B | $0.50B | 1.28 |
| 2020-06-30 | $0.50B | $0.34B | 1.47 |
| 2020-03-31 | $0.45B | $0.28B | 1.60 |
| 2019-12-31 | $0.50B | $0.36B | 1.41 |
| 2019-09-30 | $0.44B | $0.32B | 1.38 |
| 2019-06-30 | $0.35B | $0.20B | 1.74 |
| 2019-03-31 | $0.31B | $0.14B | 2.20 |
| 2018-12-31 | $0.35B | $0.20B | 1.71 |
| 2018-09-30 | $0.30B | $0.16B | 1.91 |
| 2018-06-30 | $0.24B | $0.11B | 2.06 |
| 2018-03-31 | $0.25B | $0.12B | 2.03 |
| 2017-12-31 | $0.16B | $0.14B | 1.19 |
| 2017-09-30 | $0.11B | $0.09B | 1.25 |
| 2016-12-31 | $0.10B | $0.10B | 1.05 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.568B | $0.183B |
| Zepp Health Corp. developed a platform of proprietary technology including AI chips, biometric sensors and health data algorithms, which drive a broadening line of smart health products for consumers and analytics services for insurers, healthcare providers, employers, drug and treatment companies. Zepp Health Corp., formerly known as Huami Corporation, is based in CUPERTINO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.466B | 59.12 |
| Tempus AI (TEM) | United States | $12.696B | 0.00 |
| Doximity (DOCS) | United States | $11.914B | 53.01 |
| Hims & Hers Health (HIMS) | United States | $9.534B | 78.11 |
| IRhythm Technologies (IRTC) | United States | $5.093B | 0.00 |
| Hinge Health (HNGE) | United States | $4.374B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.663B | 39.16 |
| Privia Health (PRVA) | United States | $2.603B | 192.82 |
| Heartflow (HTFL) | $2.489B | 0.00 | |
| Enovis (ENOV) | United States | $1.740B | 9.20 |
| Phreesia (PHR) | United States | $1.681B | 0.00 |
| 10x Genomics (TXG) | United States | $1.669B | 0.00 |
| Omnicell (OMCL) | United States | $1.466B | 28.24 |
| Schrodinger (SDGR) | United States | $1.428B | 0.00 |
| Azenta (AZTA) | United States | $1.388B | 60.58 |
| Clover Health Investments (CLOV) | United States | $1.292B | 0.00 |
| Claritev (CTEV) | United States | $1.115B | 0.00 |
| Evolent Health (EVH) | United States | $1.057B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.660B | 0.00 |
| Veradigm (MDRX) | United States | $0.520B | 0.00 |
| Standard BioTools (LAB) | United States | $0.485B | 0.00 |
| Talkspace (TALK) | United States | $0.430B | 128.50 |
| Butterfly Network (BFLY) | United States | $0.347B | 0.00 |
| Carlsmed (CARL) | $0.333B | 0.00 | |
| TruBridge (TBRG) | United States | $0.293B | 51.40 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.237B | 0.00 |
| Outset Medical (OM) | United States | $0.237B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.214B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.211B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.190B | 0.00 |
| CapsoVision (CV) | United States | $0.182B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.137B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.119B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 5.23 |
| American Well (AMWL) | United States | $0.115B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.086B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.074B | 0.00 |
| Pulmonx (LUNG) | United States | $0.062B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| HeartBeam (BEAT) | United States | $0.038B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.018B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |